ADGC Publications

Found 6 results
Filters: Author is Cruchaga, Carlos  [Clear All Filters]
2014
Escott-Price V, Bellenguez C, San Wang L-, Choi S-H, Harold D, Jones L, Holmans P, Gerrish A, Vedernikov A, Richards A et al..  2014.  Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease.. PLoS One. 9(6):e94661.
Benitez BA, Jin SChih, Guerreiro R, Graham R, Lord J, Harold D, Sims R, Lambert J-C, J Gibbs R, Bras J et al..  2014.  Missense variant in TREML2 protects against Alzheimer's disease.. Neurobiol Aging. 35(6):1510.e19-26.
2011
Bailey M, Kauwe JSK, Cruchaga C, McKean D, Mayo K, Bertlesen S, Hinrichs A, Fagan A, Holtzman D, Goate AM.  2011.  Association study of recently reported AD risk variants with cerebrospinal fluid AD biomarker levels. AAIC (ICAD) 2011, Paris, France.
Naj AC, Jun G, Beecham GW, San Wang L-, Vardarajan BNarayan, Buros J, Gallins PJ, Buxbaum JD, Jarvik GP, Crane PK et al..  2011.  Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.. Nat Genet. 43(5):436-41.
Kauwe JSK, Cruchaga C, McKean D, Bailey M, Patty D, Mayo K, Bertlesen S, Hinrichs A, Fagan A, Holtzman D et al..  2011.  Genome-wide association analyses using cerebrospinal fluid Aβ42 levels as endophenotype for Alzheimer’s disease. ASHG/ICHG 2011 (Montreal, Canada).
Cruchaga C, Kauwe JSK, McKean D, Bailey M, Patty D, Mayo K, Bertlesen S, Hinrichs A, Peskind E, Li G et al..  2011.  Genome-wide association analyses using cerebrospinal fluid tau and phospho-tau and Aβ42 levels as endophenotypes for Alzheimer’s disease. AAIC (ICAD) 2011, Paris, France.